Literature DB >> 20674984

Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans.

Sooyoung Bhang1, Joon-Ho Ahn, Sam-Wook Choi.   

Abstract

BACKGROUND: Polymorphisms in the brain-derived neurotrophic factor (BDNF) val66met and serotonin transporter gene-linked promoter region (5-HTTLPR) are associated with alterations in mood and BDNF protein, but the effects of two genetic variations on the serum level of BDNF is unclear. Therefore, we sought to explore the effects of two polymorphisms on serum levels of BDNF in healthy subjects.
METHODS: One hundred healthy Korean subjects were genotyped. Serum levels of BDNF were measured with enzyme-linked immunoassay, and factors (sex, age, body mass index, alcohol and smoking) that can affect BDNF level were evaluated. The effects of these two genetic variations on serum levels of BDNF were tested using an analysis of covariance.
RESULTS: We found that serum levels of BDNF were significantly affected by the factor 'genotype' (met carrier vs. val homozygote) (F=4.618, p=0.034) and (s homozygote vs. l carrier) (F=3.965, p=0.049), respectively. Moreover, subjects with s homozygosity at the 5-HTTLPR and BDNF met carriers (16.2±7.9 ng/ml) had lower serum levels of BDNF as compared with those with l carriers of the 5-HTTLPR in combination with BDNF val homozygosity (21.7±4.4 g/ml) (p=0.024). LIMITATIONS: A larger study will be needed to confirm this additive effect of both risk genotypes.
CONCLUSIONS: In this study, we report for the first time that healthy subjects who were homozygous for s at 5HTTLPR and the met allele of the BDNF val66met polymorphism displayed significantly lower serum levels of BDNF. Our findings might contribute to a better understanding of the effect of BDNF and 5-HTTLPR gene on serum BDNF level in humans.
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674984     DOI: 10.1016/j.jad.2010.07.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  15 in total

1.  Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study.

Authors:  Antonio Terracciano; Maria Grazia Piras; Monia Lobina; Antonella Mulas; Osorio Meirelles; Angelina R Sutin; Wayne Chan; Serena Sanna; Manuela Uda; Laura Crisponi; David Schlessinger
Journal:  World J Biol Psychiatry       Date:  2011-11-02       Impact factor: 4.132

2.  Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus.

Authors:  Aysun Coskunoglu; Seda Orenay-Boyacioglu; Artuner Deveci; Mustafa Bayam; Ece Onur; Arzu Onan; Fethi S Cam
Journal:  Noise Health       Date:  2017 May-Jun       Impact factor: 0.867

3.  Genetic susceptibility to family environment: BDNF Val66met and 5-HTTLPR influence depressive symptoms.

Authors:  Elizabeth D Dalton; Constance L Hammen; Jake M Najman; Patricia A Brennan
Journal:  J Fam Psychol       Date:  2014-10-27

4.  Genetic sensitivity to the caregiving context: the influence of 5httlpr and BDNF val66met on indiscriminate social behavior.

Authors:  Stacy S Drury; Mary M Gleason; Katherine P Theall; Anna T Smyke; Charles A Nelson; Nathan A Fox; Charles H Zeanah
Journal:  Physiol Behav       Date:  2011-11-23

5.  Depression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failure.

Authors:  Liang-Jen Wang; Chih-Ken Chen; Heng-Jung Hsu; I-Wen Wu; Chiao-Yin Sun; Chin-Chan Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-05       Impact factor: 2.570

6.  The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse.

Authors:  Shareefa Dalvie; Dan J Stein; Karestan Koenen; Valerie Cardenas; Natalie L Cuzen; Raj Ramesar; George Fein; Samantha J Brooks
Journal:  BMC Psychiatry       Date:  2014-12-16       Impact factor: 3.630

7.  BDNF Overexpression in the Ventral Hippocampus Promotes Antidepressant- and Anxiolytic-Like Activity in Serotonin Transporter Knockout Rats.

Authors:  Danielle M Diniz; Francesca Calabrese; Paola Brivio; Marco A Riva; Joanes Grandjean; Judith R Homberg
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

8.  Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-Naïve Schizophrenia.

Authors:  Sunil Vasu Kalmady; Ganesan Venkatasubramanian; Venkataram Shivakumar; Dania Jose; Vasanthapuram Ravi; Bangalore N Gangadhar
Journal:  Front Psychiatry       Date:  2013-07-02       Impact factor: 4.157

9.  The functional epistasis of 5-HTTLPR and BDNF Val66Met on emotion processing: a preliminary study.

Authors:  Tim Outhred; Pritha Das; Carol Dobson-Stone; Kristi Griffiths; Kim L Felmingham; Richard A Bryant; Gin Malhi; Andrew H Kemp
Journal:  Brain Behav       Date:  2012-10-03       Impact factor: 2.708

10.  BDNF Val66Met Polymorphism on Functional MRI During n-Back Working Memory Tasks.

Authors:  Chih-Chung Chen; Chi-Jen Chen; Dean Wu; Nai-Fang Chi; Po-Chih Chen; Yen-Peng Liao; Hung-Wen Chiu; Chaur-Jong Hu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.